Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

BACKGROUND The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to update cancer rates and trends in the United States. This report updates statistics on lung, female breast, prostate, and colorectal cancers and highlights the uses of selected surveillance data to assist development of state-based cancer control plans. METHODS Age-adjusted incidence rates from 1996 through 2000 are from state and metropolitan area cancer registries that met NAACCR criteria for highest quality. Death rates are based on underlying cause-of-death data. Long-term trends and rates for major racial and ethnic populations are based on NCI and CDC data. Incidence trends from 1975 through 2000 were adjusted for reporting delays. State-specific screening and risk factor survey data are from the CDC and other federal and private organizations. RESULTS Cancer incidence rates for all cancer sites combined increased from the mid-1970s through 1992 and then decreased from 1992 through 1995. Observed incidence rates for all cancers combined were essentially stable from 1995 through 2000, whereas the delay-adjusted trend showed an increase that had borderline statistical significance (P =.05). Increases in the incidence rates of breast cancer in women and prostate cancer in men offset a long-term decrease in lung cancer in men. Death rates for all cancer sites combined decreased beginning in 1994 and stabilized from 1998 through 2000, resulting in part from recent revisions in cause-of-death codes. Death rates among men continued to decline throughout the 1990s, whereas trends in death rates among women were essentially unchanged from 1998 through 2000. Analysis of state data for the leading cancers revealed mixed progress in achieving national objectives for improving cancer screening, risk factor reduction, and decreases in mortality. CONCLUSIONS Overall cancer incidence and death rates began to stabilize in the mid- to late 1990s. The recent increase in the delay-adjusted trend will require monitoring with additional years of data. Further reduction in the burden of cancer is possible but will require the continuation of strong federal, state, local, and private partnerships to increase dissemination of evidence-based cancer control programs to all segments of the population.

[1]  P. W. Bowman,et al.  PHS Public Health Service , 1963 .

[2]  Education Welfare.,et al.  Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .

[3]  C. Fletcher,et al.  Smoking and health. , 1970, WHO chronicle.

[4]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[5]  H. Hogan The 1990 Post-Enumeration Survey: operations and results. , 1993, Journal of the American Statistical Association.

[6]  J. Mclaughlin,et al.  Comparability of the death certificate and the 1986 National Mortality Followback Survey. , 1993, Vital and health statistics. Series 2, Data evaluation and methods research.

[7]  J. Kelsey Breast cancer epidemiology: summary and future directions. , 1993, Epidemiologic reviews.

[8]  C. Moertel Chemotherapy for colorectal cancer. , 1994, The New England journal of medicine.

[9]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[10]  B. Hulka,et al.  Breast cancer: cause and prevention , 1995, The Lancet.

[11]  D C Slawson,et al.  Efficacy of screening mammography. , 1995, The Journal of family practice.

[12]  Z. Yuan,et al.  Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. , 1996, American journal of public health.

[13]  L. Kinlen Mortality from smoking in developed countries 1950-2000 , 1996, British Journal of Cancer.

[14]  J. Mandelblatt,et al.  The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. , 1996, American journal of public health.

[15]  L. Kolonel,et al.  Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. , 1997, Cancer research.

[16]  B Barnwell,et al.  SUDAAN User's Manual, Release 7.5, , 1997 .

[17]  Daniel S. Miller,et al.  Cancer incidence and mortality, 1973‐1995 , 1998 .

[18]  G. Colditz,et al.  Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. , 1998, Journal of the National Cancer Institute.

[19]  P. Sorlie,et al.  Quality of death rates by race and Hispanic origin: a summary of current research, 1999. , 1999, Vital and health statistics. Series 2, Data evaluation and methods research.

[20]  Jacques Ferlay,et al.  Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.

[21]  R. Hiatt,et al.  A new strategy for cancer control research. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  Daniel S. Miller,et al.  Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.

[23]  B. Smedley,et al.  The unequal burden of cancer : an assessment of NIH research and programs for ethnic minorities and the medically underserved , 1999 .

[24]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[25]  L. Tabár,et al.  The natural history of breast carcinoma , 1999, Cancer.

[26]  T. Byers,et al.  The American Cancer Society challenge goals , 1999, Cancer.

[27]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[28]  B. Hankey,et al.  The surveillance, epidemiology, and end results program: a national resource. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  Edward L. Korn,et al.  Analysis of Health Surveys , 1999 .

[30]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[31]  J. Potter,et al.  Colorectal cancer: molecules and populations. , 1999, Journal of the National Cancer Institute.

[32]  R. Smith,et al.  Breast cancer screening among women younger than age 50: A current assessment of the issues , 2000, CA: a cancer journal for clinicians.

[33]  R A Stephenson,et al.  Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. , 2000, Journal of the National Cancer Institute.

[34]  Daniel S. Miller,et al.  The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer , 2000, Cancer.

[35]  Joseph V. Simone,et al.  Enhancing Data Systems to Improve the Quality of Cancer Care , 2000 .

[36]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[37]  L. Tabár,et al.  Beyond randomized controlled trials , 2001, Cancer.

[38]  D K Wagener,et al.  Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. , 2001, Journal of the National Cancer Institute.

[39]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[40]  C. Begg,et al.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.

[41]  H M Rosenberg,et al.  Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[42]  Peter C Gøtzsche,et al.  Cochrane review on screening for breast cancer with mammography , 2001, The Lancet.

[43]  D. Gunnell,et al.  International trends in prostate‐cancer mortality in the “PSA era” , 2001, International journal of cancer.

[44]  A. Neugut,et al.  Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. , 2001, Cancer journal.

[45]  P. Boyle,et al.  The epidemiology of prostate cancer. , 2003, The Urologic clinics of North America.

[46]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[47]  Harry J de Koning,et al.  Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial , 2002, International journal of cancer.

[48]  E. Feuer,et al.  Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.

[49]  D. Lubeck,et al.  Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. , 2002, Urology.

[50]  C. Gross,et al.  State expenditures for tobacco-control programs and the tobacco settlement. , 2002, The New England journal of medicine.

[51]  C. Lynch,et al.  Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  Michael J Thun,et al.  Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. , 2002, Journal of the National Cancer Institute.

[53]  H. Sox,et al.  Screening Mammography for Younger Women: Back to Basics , 2002, Annals of Internal Medicine.

[54]  E. Feuer,et al.  Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.

[55]  Ahmedin Jemal,et al.  Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.

[56]  Ric Skinner,et al.  Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. , 2002, Journal of public health management and practice : JPHMP.

[57]  L. Clegg,et al.  Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[59]  Daniel B Kopans,et al.  The most recent breast cancer screening controversy about whether mammographic screening benefits women at any age: nonsense and nonscience. , 2003, AJR. American journal of roentgenology.

[60]  Lisa M. Schwartz,et al.  Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? , 2003, JAMA.

[61]  Susan J. Curry,et al.  Fulfilling the Potential of Cancer Prevention and Early Detection , 2003 .

[62]  D. Ciliska,et al.  Diffusion and dissemination of evidence-based cancer control interventions. , 2003, Evidence report/technology assessment.

[63]  W. P. Evans,et al.  American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 , 2003, CA: a cancer journal for clinicians.

[64]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[65]  G. Beck,et al.  A randomized trial of aspirin to prevent colorectal adenomas. , 2003, The New England journal of medicine.

[66]  S. Feig IARC Handbooks of Cancer Prevention , 2003 .

[67]  Susan Halabi,et al.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. , 2003, The New England journal of medicine.

[68]  C. Klabunde,et al.  A national survey of primary care physicians' colorectal cancer screening recommendations and practices. , 2003, Preventive medicine.

[69]  Nancy Breen,et al.  Progress in cancer screening practices in the United States , 2003, Cancer.

[70]  A. Zaslavsky,et al.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[72]  E. Feuer,et al.  Evaluating the Impact of Population Changes in Diet, Physical Activity, and Weight Status on Population Risk for Colon Cancer (United States) , 2001, Cancer Causes & Control.

[73]  Hannah K. Weir,et al.  Building the infrastructure for nationwide cancer surveillance and control – a comparison between The National Program of Cancer Registries (NPCR) and The Surveillance, Epidemiology, and End Results (SEER) Program (United States) , 2003, Cancer Causes & Control.

[74]  E. Feuer,et al.  The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence declinein the United States , 1998, Cancer Causes & Control.